Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
In the closing of the recent trading day, Cadence Design Systems (CDNS) stood at $337.02, denoting a -2.21% move from the preceding trading day.
Unity Software Inc. (U) concluded the recent trading session at $29.27, signifying a -2.01% move from its prior day's close.
In the most recent trading session, Zscaler (ZS) closed at $142.26, indicating a -4.34% shift from the previous trading day.
In the closing of the recent trading day, Powell Industries (POWL) stood at $240.68, denoting a -1.52% move from the preceding trading day.
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $31.68, moving 3.21% from the previous trading session.
In the most recent trading session, Robinhood Markets, Inc. (HOOD) closed at $104.37, indicating a -1.87% shift from the previous trading day.
Meta Platforms (META) concluded the recent trading session at $627.17, signifying a -2.58% move from its prior day's close.
In the most recent trading session, e.l.f. Beauty (ELF) closed at $79.03, indicating a -1.09% shift from the previous trading day.
In the most recent trading session, Boeing (BA) closed at $208.65, indicating a +1.88% shift from the previous trading day.
AppLovin (APP) closed the most recent trading day at $412.48, moving 3.78% from the previous trading session.
Tesla (TSLA) delivered earnings and revenue surprises of -34.00% and +9.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
The carrier said it now expects full-year adjusted earnings per share of $3.25 to $4.25, compared with its forecast from January for at least $4.
Pfizer (PFE) is back in focus after Arbutus Biopharma and Genevant Sciences expanded their patent litigation over mRNA lipid nanoparticle technology, adding new international cases that raise legal and operational questions for the company’s COVID-19 vaccine business. See our latest analysis for Pfizer. The legal headlines around Pfizer’s mRNA vaccine coincide with a mixed price pattern, with the stock showing a 1-day share price return of 0.77% and a 7-day share price return of 2.85%, but a...
(Updates with index/price moves and company/geopolitical news from the first paragraph.) US equit
GE Vernova's $24 Billion Order Boom Isn't Enough to Stop the Selloff
Tesla reported weaker-than-expected quarterly profits on Wednesday, citing a hit from lower vehicle prices despite increased auto sales. But the company's earnings press release said profitability was dented by lower vehicle sales prices, lower revenue from regulatory credits and an unspecified "vendor cell issue" that led to an increase in "energy warranty-related charges."
The reductions follow January's company-wide layoffs
Palantir Falls as Investors Cash Out Ahead of Critical Earnings Report
IBM's Q2 prerelease for results last week had already lowered expectations for Wednesday's results.
Investing.com -- International Business Machines Corporation (NYSE:IBM) reported second-quarter results that fell short of analyst expectations, though shares rose 3% as the company had issued a profit warning last week.
Senior Business Reporter Brooke DiPalma joins Market Domination Overtime Host Josh Lipton to break down Tesla's (TSLA) second-quarter earnings, with the EV maker reporting $28.24 billion in revenue, up 26% year over year, while adjusted earnings per share came in at $0.33, missing Wall Street expectations.
Healthcare insurance company Molina Healthcare (NYSE:MOH) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 4.8% year on year to $10.87 billion. On the other hand, the company’s full-year revenue guidance of $42 billion at the midpoint came in 5.1% below analysts’ estimates. Its non-GAAP profit of $1.51 per share was 7.8% above analysts’ consensus estimates.
A closely watched social media addiction lawsuit that had been set to go to trial next week has been dropped after the plaintiff voluntarily dismissed his claims against Meta, leaving none of the major tech companies facing trial in the case.
IBM cut its annual revenue growth forecast on Wednesday, days after shocking Wall Street with a warning that corporate spending was shifting toward AI-focused data-center gear at the expense of its software and mainframe computers. The company also missed profit and revenue expectations for the second quarter ended June 30, but executives sought to reassure shareholders that customers prioritized spending on AI in the quarter but were not looking to move away from mainframes in the longer term. CEO Arvind Krishna said last week IBM had "faltered" in adapting and "numerous large deals" had slipped, sending the company's shares down 25%, its steepest one-day fall in more than a century.
Texas Instruments beat Wall Street's targets for the second quarter and guided higher than views for the current period. But TXN stock fell in extended trading.
<body><p>STORY: The iShares Russell 2000 ETF (IWM) was trading lower on Wednesday (July 22).</p><p>"The catalyst for small caps being down is a rise in interest rates," Lang said. "Small caps are anathema to higher interest rates."</p><p>"We're seeing steady rises [in rates] over the past several weeks," he noted, adding that the 10-year Treasury yield is "pushing up against 4.7%."</p><p>"Once it pushes past through 4.7%, I think the wheels come off on some of these small-cap stocks," Lang said.</p></body>
The company is narrowing its AI focus while continuing a broader cost-reduction push.
Top cryptocurrencies fell Wednesday, with Bitcoin (BTC-USD) dropping below $66,000. The CoinDesk
A Florida teen suing social-media platforms over claims their design led to mental health issues dropped his lawsuit against Meta Platforms ahead of a trial slated to begin next week in Los Angeles.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
